Last deal

$50.K

Amount

Grant

Stage

09.01.2019

Date

4

all rounds

$200.K

Total amount

General

About Company
Diasyst simplifies chronic disease management with smart solutions.

Industry

Sector :

Subsector :

Keywords :

founded date

01.01.2015

Number of employees

Company Type

For Profit

Last funding type

Grant

IPO status

Private

Description

The company's smart diabetes management application collects real-time data, analyzes it with proprietary algorithms, and provides medication intervention recommendations for healthcare teams to make effective, individualized, and safe treatment decisions. With decades of research at Emory University and the VA, Diasyst's Medication Intelligence solution empowers healthcare providers to make timely, quick, safe, and effective treatment decisions. The company's AI delivers treatment recommendations to decision-makers, helping save time, increase revenues, and maximize patient outcomes.
Contacts

Phone number

Social url